Washington, D.C. (July 15, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement regarding the Senate Health, Education, Labor and Pensions Committee’s vote in favor of the “Quality, Affordable Health Coverage for All Americans” bill:
“Senate HELP Committee passage of the ‘Quality, Affordable Health Coverage for All Americans’ bill marks an important step toward achieving comprehensive health care reform. We applaud members of the committee for their commitment to America’s patients, who deserve access to high-quality, affordable health care.
“The committee is also to be commended for assuring that the bill, in addition to providing increased patient access to needed care, also maintains the incentives for innovation that leads to the discovery and development of tomorrow’s novel new medicines.
“The road toward comprehensive health reform continues to stretch out before us. We look forward to continuing our collaborative work toward accomplishing meaningful reform this year.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.
PhRMA Internet Address: http://www.phrma.org
For information on how innovative medicines save lives, visit: http://www.innovation.org
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org
For more information on public health emergencies, visit http://www.rxresponse.org
For information on the danger of imported drugs, visit: http://www.buysafedrugs.info